NCT04356664View on ClinicalTrials.gov

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

June 18, 2026

Study Completion Date

June 18, 2026

Conditions

EndometriosisAdenomyosisInfertility, Female

Interventions

DRUG

GnRH agonist

One or two intramuscular injections of Decapeptyl 3 mg

Trial Locations (1)

92150

RECRUITING

Hopital Foch, Suresnes

All Listed Sponsors

lead

Hopital Foch

OTHER